Search results for "Highlights"
Diabetes patients with healthy lifestyles appear to have low, no excess CVD risk, study finds
An accompanying editorial called for broader international efforts to target cardiovascular risk through programs that encourage healthy lifestyles.
https://diabetes.acponline.org/archives/2019/08/09/2.htm
9 Aug 2019
Different diabetes phenotypes associated with varying prevalence of complications
Patients were categorized into five groups: mild age-related diabetes, mild obesity-related diabetes, severe autoimmune diabetes, severe insulin-resistant diabetes, and severe insulin-deficient diabetes.
https://diabetes.acponline.org/archives/2019/08/09/3.htm
9 Aug 2019
Cardiology guidance supports use of SGLT-2 inhibitors, GLP-1 receptor agonists for CV benefits in diabetes
Evidence on sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists indicates that these drugs can be used not just for glucose control but for cardiovascular (CV) risk reduction in patients with type 2 diabetes, according to a new expert pathway.
https://diabetes.acponline.org/archives/2020/08/14/1.htm
14 Aug 2020
Lowering serum urate levels with allopurinol did not improve kidney outcomes in patients with type 1 diabetes
Randomized trial participants with type 1 diabetes and mild-to-moderate diabetic kidney disease who received allopurinol or placebo had similar estimated glomerular filtration rates after three years.
https://diabetes.acponline.org/archives/2020/07/10/1.htm
10 Jul 2020
Young adults with diabetes have less favorable cardiometabolic risk profile versus those without, study finds
Compared to young adults without diabetes, those with diabetes were more likely to have obesity, elevated lipids, or hypertension and were less likely to report being physically active or consuming a healthy diet.
https://diabetes.acponline.org/archives/2019/07/12/2.htm
12 Jul 2019
Patient-centered diabetes care varies in intensity by both disease- and patient-related factors
Patients were more likely to choose more intensive care after an annual consultation if they had a high level of education, if they were concerned about illness, if they had set goals for their care, and if they had comorbid conditions.
https://diabetes.acponline.org/archives/2019/07/12/3.htm
12 Jul 2019
AHA offers new guidance on treating diabetes and heart failure
A scientific statement from the American Heart Association and the Heart Failure Society of America describes new approaches to medications, lifestyles, and the importance of multidisciplinary care that includes physicians and other clinicians.
https://diabetes.acponline.org/archives/2019/06/14/3.htm
14 Jun 2019
DPP-4 inhibitors may be effective for some cases of inpatient hyperglycemia
A narrative review considered the available evidence on use of metformin, thiazolidinediones, sulfonylureas, sodium-glucose cotransporter-2 inhibitors, and dipeptidyl peptidase-4 (DPP-4) inhibitors in the hospital.
https://diabetes.acponline.org/archives/2020/06/12/1.htm
12 Jun 2020
ADA updates standards of care related to CV, renal health in type 2 diabetes
The updates were based on findings from the industry-funded CREDENCE (Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy) trial.
https://diabetes.acponline.org/archives/2019/06/14/2.htm
14 Jun 2019
AHA issues statement on coronary artery disease management in patients with diabetes
The American Heart Association (AHA) addressed use of antithrombotics, hypertension drugs, and cholesterol therapies in patients with stable coronary artery disease and diabetes, among other recommendations.
https://diabetes.acponline.org/archives/2020/05/08/1.htm
8 May 2020